Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Stereotactic Transplantation of Human Amniotic Epithelial Stem Cells (hAESCs) in the Treatment of Parkinson's Disease (PD)

NCT04414813 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT04414813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Stereotactic Transplantation of Human Amniotic Epithelial Stem Cells (hAESCs) in the Treatment of Parkinson's Disease (PD)
Lead sponsor
Shanghai East Hospital
Phase
Phase 1
Overall status
Completed
Start date
October 8, 2020
Completion date
February 8, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease